Universe Pharmaceuticals Inc.

UPC | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.67

+$0.03 (+0.65%)

At close: Sep 22, 2026, 4:00 PM ET

$4.66

-$0.01 (-0.21%)

After-hours: Sep 22, 2026, 6:56 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.93M

Enterprise Value $-16.43M

Beta 1.59

Average Volume 1.62M

Shares Outstanding (Diluted) 563.34K

Shares Change YoY 9170%

Institutional Ownership N/A

Exchange NASDAQ

ISIN KYG9442G1385

Price Performance

Price Change 1M -8.3%

Price Change 3M 59.5%

Price Change 6M 115.6%

Price Change YTD 16.6%

Price Change 1Y 9.2%

Price Change 3Y -99.3%

Price Change 5Y -99.9%

1M CAGR (ann.) -16.6%

1Y CAGR (ann.) 11.8%

5Y CAGR (ann.) -77.8%

All-Time CAGR -77.5%

Valuation

PE Ratio -1.41

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.00

PS Ratio 0.17

Forward PS N/A

PB Ratio 0.06

P/FCF Ratio -0.25

P/Adj. FCF Ratio -0.25

P/OCF Ratio -0.23

EV/Sales -0.93

EV/EBIT 9.21

EV/EBITDA 12.59

EV/FCF 1.33

Earnings Yield -71.1%

FCF Yield -404.5%

Adj. FCF Yield -404.5%

Financial Health

Net Cash $19.5M

Total Debt $9.55M

Cash & Short-Term Investments $29.05M

Total Assets $71.47M

Current Ratio 4.05

Quick Ratio 3.75

Debt / Equity Ratio 0.17

Debt / EBITDA -7.32

Debt / FCF -0.77

OCF / Debt -1.25

Interest Coverage -9.11

Altman Z-Score 0.67

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 35.9%

Operating Profit Margin -11.8%

EBITDA Margin -7.4%

Net Profit Margin -10.9%

FCF Margin -69.8%

Adj. FCF Margin -69.8%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -2.7%

Return on Equity -3.5%

Return on Invested Capital -3.2%

Return on Capital Employed -3.6%

Return on Tangible Assets -2.7%

Historical Growth (CAGR)

Revenue CAGR 3Y -17.8%

Revenue CAGR 5Y -10.3%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -81.7%

EPS CAGR 5Y -111.3%

EPS CAGR 10Y N/A

FCF CAGR 3Y -10.9%

FCF CAGR 5Y 19.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Apr 21, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-11.91M

Free Cash Flow $-12.39M

Adj. Free Cash Flow $-12.39M

FCF Per Share -$22

OCF Per Share -$21.14

OCF/S Ratio -67.1%

Income Statement

Revenue $17.74M

Gross Profit $6.36M

Operating Income $-2.09M

EBITDA $-1.31M

Net Income $-1.94M

EPS (Diluted) -$3.45

Revenue / Employee $82.14K

Profit / Employee $-8.99K

Employees 216